212 related articles for article (PubMed ID: 28586149)
1. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.
Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O
J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149
[TBL] [Abstract][Full Text] [Related]
2. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
[TBL] [Abstract][Full Text] [Related]
3. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
[TBL] [Abstract][Full Text] [Related]
4. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
5. Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.
Deconinck S; Tersteeg C; Bailleul E; Delrue L; Vandeputte N; Pareyn I; Itzhar-Baikian N; Deckmyn H; De Meyer SF; Vanderheyden M; Vanhoorelbeke K
Res Pract Thromb Haemost; 2018 Oct; 2(4):762-766. PubMed ID: 30397685
[TBL] [Abstract][Full Text] [Related]
6. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B
Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469
[TBL] [Abstract][Full Text] [Related]
7. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
[TBL] [Abstract][Full Text] [Related]
8. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients.
Crow S; Milano C; Joyce L; Chen D; Arepally G; Bowles D; Thomas W; Ortiz NV
ASAIO J; 2010; 56(5):441-5. PubMed ID: 20613494
[TBL] [Abstract][Full Text] [Related]
10. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
[TBL] [Abstract][Full Text] [Related]
12. Association between the severity of acquired von Willebrand syndrome and gastrointestinal bleeding after continuous-flow left ventricular assist device implantation.
Sakatsume K; Saito K; Akiyama M; Sasaki K; Kawatsu S; Takahashi G; Adachi O; Kawamoto S; Horiuchi H; Saiki Y
Eur J Cardiothorac Surg; 2018 Nov; 54(5):841-846. PubMed ID: 29741685
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
14. Changes in Von Willebrand factor profile predicts clinical outcomes in patients on mechanical circulatory support.
Oezpeker C; Zittermann A; Baurichter D; Morshuis M; Prohaska W; Kassner A; Erkilet G; Gummert J; Milting H
J Card Surg; 2018 Oct; 33(10):693-702. PubMed ID: 30199919
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
[TBL] [Abstract][Full Text] [Related]
17. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
[TBL] [Abstract][Full Text] [Related]
18. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
[TBL] [Abstract][Full Text] [Related]
19. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
Bartoli CR; Kang J; Motomura T
J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
[TBL] [Abstract][Full Text] [Related]
20. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
Rauch A; Caron C; Vincent F; Jeanpierre E; Ternisien C; Boisseau P; Zawadzki C; Fressinaud E; Borel-Derlon A; Hermoire S; Paris C; Lavenu-Bombled C; Veyradier A; Ung A; Vincentelli A; van Belle E; Lenting PJ; Goudemand J; Susen S
Thromb Haemost; 2016 May; 115(5):950-9. PubMed ID: 26791163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
